High-Risk, Antepartum Flashcards
(60 cards)
Cerclage Indications
- history
- physical exam
- ultrasound
Delivery Timing for PPROM
Mgmt
~34w0d
inpatient, steroids, latency abx, MgSO4
When to give MgSO4 for fetal neuroprotection (GA)
≤ 32w0d
History-Indicated Cerclage Reasons:
- hx painless cervical dilation in 2T
or - hx of prior cerclage
Physical Exam-Indicated Cerclage Reason:
- 1-4cm dilation (painless) in mid-second trimester
aka “rescue” cerclage (avg of 4wks GA gained!)
Sono-Indicated Cerclage Reason
CL <25mm
<24wks
hx PTB <34w
MCC fetal death in mono-mono twins
cord entanglement (rate as high 17%)
“TAPS” stands for
Twin Anemia Polycthemia Sequence
TAPS definition
MoA
form of TTTS
tiny AVS anastamoses (not large AVS like TAPS)
can occur after incomplete laser ablation for TTTS
TAPS vs TTTS differences
-AVS anastamoses size
-TAPS = normal amniotic fluid, polycthemia/anemia
-TTTS = different amniotic fluid levels, poly/oligo
TRAP sequence stands for…
Twin Reversed Arterial Perfusion sequence
TRAPS sequence findings
type of twinning
acardiac twin
pump twin (supplies blood to itself and acardiac twin)
monochorionic
Antenatal Surveillance for maternal anti-SSA/SSB+
(timing, GA)
Looking for what?
16-26wks GA: fetal echo qWeek
26-34wks GA: fetal echo q 2wks
neonatal lupus -> fetal heart block
Cervical Insufficiency risk factors
- cervical trauma / procedures (D&C, LEEP, CKC)
- congenital cervical defects / uterine anomalies
- collagen d/o
- DES exposure
- inc IL-8
Nifedipine as tocolytic can be used up to what GA?
<34w
indomethacin as tocolytic can be used up to what GA? (and why?)
<32w (premature closure of ductus arteriosus)
MgSO4 for neuroprotection
GA? timing (when do you stop?)
what does it protect against?
GA: <32w
Stop: if delivery not imminent (~4hrs away) after risk has passed(i.e. after 24hrs monitoring)
protects against: CP (does not reduce hypoxic-ischemic encephalopathy)
B2 agonist (tocolytic) adverse fx
maternal tachy
palpitations
pulmonary edema (MoA is sodium retention -> vol overload)
Nifedipine (CCB tocolytic) adverse fx
-maternal dizziness, flushing, hypotension
-decreased heart contractility -> maternal brady
MoA: less calcium ,less ctx
monochorionic twin demise ->
risk for surviving twin
neuro, death
neuro injury: 18%
death: 15%
dichorionic twin demise ->
risk for surviving twin
neuro, death
neuro injury: 1%
death: 3%
PPROM incidence in U.S.
2-3% pregnancies
AFLP: deficiency
Outocmes
LCHAD deficiency
increase in maternal fatty acid levels -> hepatic toxicity
TTP MoA
outcomes
reduces ADAMSTs13 activity (a vWF-cleaving metalloprotease)
uncleavesd VWF -> aggregation -> microangiopathy ->TTP